Symbol,Name,HGNC_ID,Evidence,Test method,Test in,Test setting,Pathway,Confidence,Caution,Protein encoded,UniProtKB,PMID,Remark
RPL8,Ribosomal protein L8,HGNC:10368,Required in erastin-induced ferroptosis. Silencing of it conferred against erastin-induced ferroptosis.,"shRNA screening, qPCR, gene silencing",Human,NRAS mutant HT-1080 fibrosarcoma cells; KRAS mutant Calu-1 non small cell lung cancer cell,RPL8 :+: Ferroptosis,Validated,_NA_,60S ribosomal protein L8,P62917 (RL8_HUMAN),22632970,_NA_
IREB2,Iron response element binding protein 2,HGNC:6115,Required in erastin-induced ferroptosis. Silencing of it conferred against erastin-induced ferroptosis.,"shRNA screening, qPCR, gene silencing",Human,NRAS mutant HT-1080 fibrosarcoma cells; KRAS mutant Calu-1 non small cell lung cancer cell,IREB2 :+: Ferroptosis,Validated,_NA_,Iron-responsive element-binding protein 2,P48200 (IREB2_HUMAN),22632970,_NA_
ATP5MC3,ATP synthase membrane subunit c locus 3,HGNC:843,Required in erastin-induced ferroptosis. Silencing of it conferred against erastin-induced ferroptosis.,"shRNA screening, qPCR, gene silencing",Human,NRAS mutant HT-1080 fibrosarcoma cells; KRAS mutant Calu-1 non small cell lung cancer cell,ATP5MC3 :+: Ferroptosis,Validated,_NA_,ATP synthase F(0) complex subunit C3,P48201 (AT5G3_HUMAN),22632970,ATP5G3 in article
CS,Citrate synthase,HGNC:2422,Required in erastin-induced ferroptosis. Silencing of it conferred against erastin-induced ferroptosis.,"shRNA screening, qPCR, gene silencing",Human,NRAS mutant HT-1080 fibrosarcoma cells; KRAS mutant Calu-1 non small cell lung cancer cell,CS :+: Ferroptosis,Validated,_NA_,Citrate synthase,O75390 (CISY_HUMAN),22632970,_NA_
EMC2,ER membrane protein complex subunit 2,HGNC:28963,Required in erastin-induced ferroptosis. Silencing of it conferred against erastin-induced ferroptosis.,"shRNA screening, qPCR, gene silencing",Human,NRAS mutant HT-1080 fibrosarcoma cells; KRAS mutant Calu-1 non small cell lung cancer cell,EMC2 :+: Ferroptosis,Validated,_NA_,ER membrane protein complex subunit 2,Q15006 (EMC2_HUMAN),22632970,TTC35 in article
ACSF2,Acyl-CoA synthetase family member 2,HGNC:26101,Required in erastin-induced ferroptosis. Silencing of it conferred against erastin-induced ferroptosis.,"shRNA screening, qPCR, gene silencing",Human,NRAS mutant HT-1080 fibrosarcoma cells; KRAS mutant Calu-1 non small cell lung cancer cell,ACSF2 :+: Ferroptosis,Validated,_NA_,Medium-chain acyl-CoA ligase ACSF2,Q96CM8 (ACSF2_HUMAN),22632970,_NA_
NOX1,Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) 1,HGNC:7889,Suppresses erastin-induced ferroptosis when inhibited by inhibitor.,Inhibition test by diphenylene iodonium (DPI) and GKT137831.,Human,KRAS mutant Calu-1 non small cell lung cancer cell,NOX1 :+: Ferroptosis,Deduced,The presented inhibition study is not sufficient to confirm its role in ferroptosis.,NADPH oxidase 1,Q9Y5S8 (NOX1_HUMAN),22632970,_NA_
CYBB,Cytochrome b-245 beta chain,HGNC:2578,Suppresses erastin-induced ferroptosis when inhibited by inhibitor.,Inhibition test by diphenylene iodonium (DPI).,Human,KRAS mutant Calu-1 non small cell lung cancer cell,CYBB :+: Ferroptosis,Deduced,The presented inhibition study is not sufficient to confirm its role in ferroptosis.,Cytochrome b-245 heavy chain,P04839 (CY24B_HUMAN),22632970,NOX2 in article
NOX3,Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) 3,HGNC:7890,Suppresses erastin-induced ferroptosis when inhibited by inhibitor.,Inhibition test by diphenylene iodonium (DPI).,Human,KRAS mutant Calu-1 non small cell lung cancer cell,NOX3 :+: Ferroptosis,Deduced,The presented inhibition study is not sufficient to confirm its role in ferroptosis.,NADPH oxidase 3,Q9HBY0 (NOX3_HUMAN),22632970,_NA_
NOX4,Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) 4,HGNC:7891,Suppresses erastin-induced ferroptosis when inhibited by inhibitor.,Inhibition test by diphenylene iodonium (DPI) and GKT137831.,Human,KRAS mutant Calu-1 non small cell lung cancer cell,NOX4 :+: Ferroptosis,Deduced,The presented inhibition study is not sufficient to confirm its role in ferroptosis.,NADPH oxidase 4,Q9NPH5 (NOX4_HUMAN),22632970,_NA_
NOX5,Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) 5,HGNC:14874,Suppresses erastin-induced ferroptosis when inhibited by inhibitor.,Inhibition test by diphenylene iodonium (DPI).,Human,KRAS mutant Calu-1 non small cell lung cancer cell,NOX5 :+: Ferroptosis,Deduced,The presented inhibition study is not sufficient to confirm its role in ferroptosis.,NADPH oxidase 5,Q96PH1 (NOX5_HUMAN),22632970,_NA_
DUOX1,Dual oxidase 1,HGNC:3062,Suppresses erastin-induced ferroptosis when inhibited by inhibitor.,Inhibition test by diphenylene iodonium (DPI).,Human,KRAS mutant Calu-1 non small cell lung cancer cell,DUOX1 :+: Ferroptosis,Deduced,The presented inhibition study is not sufficient to confirm its role in ferroptosis.,Dual oxidase 1,Q9NRD9 (DUOX1_HUMAN),22632970,_NA_
DUOX2,Dual oxidase 2,HGNC:13273,Suppresses erastin-induced ferroptosis when inhibited by inhibitor.,Inhibition test by diphenylene iodonium (DPI).,Human,KRAS mutant Calu-1 non small cell lung cancer cell,DUOX2 :+: Ferroptosis,Deduced,The presented inhibition study is not sufficient to confirm its role in ferroptosis.,Dual oxidase 2,Q9NRD8 (DUOX2_HUMAN),22632970,_NA_
G6PD,Glucose-6-phosphate dehydrogenase,HGNC:4057,Required in erastin-induced ferroptosis.,"shRNA silencing, RT-qPCR",Human,KRAS mutant Calu-1 non small cell lung cancer cell,G6PD :+: Ferroptosis,Validated,_NA_,Glucose-6-phosphate 1-dehydrogenase,P11413 (G6PD_HUMAN),22632970,_NA_
PGD,Phosphoglycerate dehydrogenase,HGNC:8891,Required in erastin-induced ferroptosis.,"shRNA silencing, RT-qPCR",Human,KRAS mutant Calu-1 non small cell lung cancer cell,PGD :+: Ferroptosis,Validated,_NA_,6-phosphogluconate dehydrogenase,P52209 (6PGD_HUMAN),22632970,_NA_
VDAC2,Valtage-dependent anion channels 2,HGNC:12672,Required in erastin-induced ferroptosis.,"shRNA silencing, RT-qPCR",Human,KRAS mutant Calu-1 non small cell lung cancer cell,VDAC2 :+: Ferroptosis,Validated,_NA_,Voltage-dependent anion-selective channel protein 2,P45880 (VDAC2_HUMAN),22632970,_NA_
PIK3CA,"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",HGNC:8975,Inhibitor blocked ferroptotic cell death.,Cell survival assays,Mice,HT22 cells,"PIK3CA :-: GSH, GSH :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,Also involved in necrosis and apoptosis.,Phosphatidylinositol 4,P42336 (PK3CA_HUMAN),24739485,PI3Kalpha in article
FLT3,Fms related tyrosine kinase 3,HGNC:3765,Inhibitor blocked ferroptotic cell death.,Cell survival assays,Mice,HT22 cells,"FLT3 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,Also involved in necrosis and apoptosis.,Receptor-type tyrosine-protein kinase FLT3,P36888 (FLT3_HUMAN),24739485,_NA_
SCP2,Sterol carrier protein 2,HGNC:10606,"SCP-2 inhibitors showed anti-ferroptotic activity, which was substantiated by knocking down SCP-2 in Gpx4−/− cells.","Cell viability test, siRNA-mediated knockdown.",Mice,PZL cells,SCP2 :+: Ferroptosis,Validated,Transient effect. Other translocases may work in parallel.,Non-specific lipid-transfer protein,P22307 (NLTP_HUMAN),25402683,_NA_
TP53,Tumor protein p53,HGNC:11998,Inhibits cystine uptake and sensitizes cells to ferroptosis. Erastin induced high levels of cell death in p53+/+ MEFs.,"Cell death kinetics, shRNA, western blotting, RT-PCR, ChIP assay, cystine uptake assay","Human, mice","H1299, U2OS and MCF7 cells, mouse embryonic fibroblasts","TP53 :-: SLC7A11, SLC7A11 :+: Cystine, Cystine :-: Ferroptosis",Validated,The acetylation-defective mutant (p53[3KR]) also retains the ability to induce ferroptosis upon reactive oxygen species (ROS)-induced stress.,Cellular tumor antigen p53,P04637 (P53_HUMAN),25799988,_NA_
ACSL4,Acyl-CoA synthetase long chain family member 4,HGNC:3571,Deletion of this gene likely suppress ferroptosis by limiting the membrane-resident pool of oxidation-sensitive fatty acids.,Retroviral-mediated insertional mutagenesis and sequencing,Human,Chronic myeloid leukemia cell line KBM7,ACSL4 :+: Ferroptosis,Predicted,Author prediction based on gene function.,Long-chain-fatty-acid--CoA ligase 4,O60488 (ACSL4_HUMAN),25965523,_NA_
LPCAT3,Lysophosphatidylcholine acyltransferase 3,HGNC:30244,Deletion of this gene likely suppress ferroptosis by limiting the membrane-resident pool of oxidation-sensitive fatty acids.,Retroviral-mediated insertional mutagenesis and sequencing,Human,Chronic myeloid leukemia cell line KBM7,LPCAT3 :+: Ferroptosis,Predicted,Author prediction based on gene function.,Lysophospholipid acyltransferase 5,Q6P1A2 (MBOA5_HUMAN),25965523,_NA_
NRAS,"NRAS proto-oncogene, GTPase",HGNC:7989,NRAS12V mutant protects RMS13 cells from ferroptotic cell death.,"Cell viability assessed by MTT assay, western blot",Human,RMS13 cells,NRAS :+: Ferroptosis,Deduced,Inferred as a promoter because RAS mutant is resistant to ferroptosis.,GTPase NRas,P01111 (RASN_HUMAN),26157704,_NA_
KRAS,"KRAS proto-oncogene, GTPase",HGNC:6407,KRAS12V mutant protects RMS13 cells from ferroptotic cell death.,"Cell viability assessed by MTT assay, western blot",Human,RMS13 cells,KRAS :+: Ferroptosis,Deduced,Inferred as a promoter because RAS mutant is resistant to ferroptosis.,GTPase KRas,P01116 (RASK_HUMAN),26157704,_NA_
HRAS,"HRas proto-oncogene, GTPase",HGNC:5173,HRAS12V mutant protects RMS13 cells from ferroptotic cell death.,"Cell viability assessed by MTT assay, western blot",Human,RMS13 cells,HRAS :+: Ferroptosis,Deduced,Inferred as a promoter because RAS mutant is resistant to ferroptosis.,GTPase HRas,P01112 (RASH_HUMAN),26157704,_NA_
TF,Transferrin,HGNC:11740,Essential for the induction of ferroptotic cell death. Transferrin can only interact with transferrin receptor and be transported into the cell when it is loaded with iron.,Killing activity,Mice,Mouse embryonic fibroblasts,TF :+: Ferroptosis,Validated,_NA_,Serotransferrin,P02787 (TRFE_HUMAN),26166707,Transferrin in article
TFRC,Transferrin receptor,HGNC:11763,RNAi of transferrin receptor (TfR) inhibited ferroptosis.,RNAi,Mice,Mouse embryonic fibroblasts,TFRC :+: Ferroptosis,Validated,_NA_,Transferrin receptor protein 1,P02786 (TFR1_HUMAN),26166707,Tfr in article
TFR2,Transferrin receptor 2,HGNC:11762,RNAi of transferrin receptor (TfR) inhibited ferroptosis.,RNAi,Mice,Mouse embryonic fibroblasts,TFR2 :+: Ferroptosis,Validated,_NA_,Transferrin receptor protein 2,Q9UP52 (TFR2_HUMAN),26166707,Tfr in article
SLC38A1,Solute carrier family 38 member 1,HGNC:13447,RNAi knockdown markedly blocked ferroptosis.,"RNAi knockdown, cell survival analysis",Mice,Mouse embryonic fibroblasts,"SLC38A1 :+: Glutamine, Glutamine :+: Glutamate, Glutamate :+: alpha-Ketoglutarate, alpha-Ketoglutarate :+: Ferroptosis",Validated,_NA_,Sodium-coupled neutral amino acid transporter 1,Q9H2H9 (S38A1_HUMAN),26166707,_NA_
SLC1A5,Solute carrier family 1 member 5,HGNC:10943,Pharmacological inhibition by L-g-glutamyl-p-nitroanilide or RNAi knockdown markedly blocked ferroptosis.,"RNAi knockdown, cell survival analysis",Mice,Mouse embryonic fibroblasts,"SLC1A5 :+: Glutamine, Glutamine :+: Glutamate, Glutamate :+: alpha-Ketoglutarate, alpha-Ketoglutarate :+: Ferroptosis",Validated,_NA_,Neutral amino acid transporter B(0),Q15758 (AAAT_HUMAN),26166707,_NA_
GLS2,Glutaminase 2,HGNC:29570,Both inhibitor inhibition and gene knockdown inhibit ferroptotic cell death.,"shRNA, western blot, cell viability",Mice,Mouse embryonic fibroblasts,"GSL2 :+: Glutamate, Glutamate :+: Ferroptosis",Validated,_NA_,Glutaminase liver isoform,Q9UI32 (GLSL_HUMAN),26166707,_NA_
GOT1,Glutamic-oxaloacetic transaminase 1,HGNC:4432,RNAi reduced ferroptosis.,"shRNA, qPCR, cell viability",Mice,Mouse embryonic fibroblasts,"GOT1 :+: alpha-Ketoglutarate, alpha-Ketoglutarate :+: Ferroptosis",Validated,_NA_,Aspartate aminotransferase,P17174 (AATC_HUMAN),26166707,_NA_
CARS1,Cysteinyl-tRNA synthetase 1,HGNC:1493,"Required for ferroptosis in diverse cell contexts. Knockdown of CARS inhibited erastin-induced death by preventing the induction of lipid reactive oxygen species, without altering iron homeostasis.","siRNA screen, shRNA, western blot, cell viability","Human, rat","HT-1080 fibrosarcoma cells,BJeLR fibroblast cells, Panc1 cells, A673 (Ewing’s sarcoma) and 143B (osteosarcoma) cells, PC12 cells","CARS1 :-: Transsulfuration pathway, Transsulfuration pathway :-: Ferroptosis",Validated,_NA_,Cysteine--tRNA ligase,P49589 (SYCC_HUMAN),26184909,CARS in article
TP53,Tumor protein p53,HGNC:11998,Wild type p53 can induce ferroptosis upon reactive oxygen species (ROS)-induced stress.,"Cell death quantification, western blot",Human,H1299 cells,"TP53 :-: SLC7A11, SLC7A11 :-: Ferroptosis",Validated,_NA_,Cellular tumor antigen p53,P04637 (P53_HUMAN),26218928,p53 in article
ALOX5,Arachidonate 5-lipoxygenase,HGNC:435,The 5-Lipoxygenase inhibitor zileuton protected HT22 neuronal cells from erastin-induced ferroptosis.,"Cell Viability Assay, ROS measurement",Mice,HT22 mouse neuronal cell line,"ALOX5 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Arachidonate 5-lipoxygenase,P09917 (LOX5_HUMAN),26235588,5-LOX in article
KEAP1,Kelch like ECH associated protein 1,HGNC:23177,Knockdown of Keap1 reversed loss of p62-increased degradation of NRF2 in ferroptosis. Keap1 knockdown led to resistance to erastin-induced and sorafenib-induced growth inhibition with decreased ferroptotic events in the absence or presence of p62 knockdown.,"Western blot, shRNA knockdown, cell viability","Human, mice","HepG2, Hepa1‐6, Hep3B, and SNU‐182 cells","KEAP1 :-: NFE2L2, NFE2L2 :-: Ferroptosis",Validated,_NA_,Kelch-like ECH-associated protein 1,Q14145 (KEAP1_HUMAN),26403645,_NA_
HMOX1,Heme oxygenase 1,HGNC:5013,"Zinc protoporphyrin IX, a HO-1 inhibitor, prevented Erastin-triggered ferroptotic cancer cell death. Overexpression accelerates erastin-induced cell death.","Cell viability assay, qRT-PCR, western blot","Human, mice","HT-1080 fibrosarcoma cells, mice lung fibroblastic cells","HMOX1 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,"Other articles (PMID 26403645, 28515173) suggest it a suppressor.",Heme oxygenase 1,P09601 (HMOX1_HUMAN),26405158,HO-1 in article
TP53,Tumor protein p53,HGNC:11998,p53^3KR/3KR Xrcc4^-/- MEF cells are very sensitive to ferroptosis. Stabilized in the spleens of p53^3KR/3KR Xrcc4^-/- mice which enables to prevent the development of pro-B-cell lymphomas.,"Western blot, qRT-PCR, cell viability",Mice,"p53^3KR/3KR Xrcc4^-/- MEF cells, p53^3KR/3KR Xrcc4^-/- mice","TP53 :-: SLC7A11, SLC7A11 :-: Ferroptosis",Validated,_NA_,Cellular tumor antigen p53,P04637 (P53_HUMAN),26943586,p53 in article
TP53,Tumor protein p53,HGNC:11998,Incubation with erastin led to profound cell death in wild-type MEFs.,"Cell viability assay, phase-contrast microscopy","Human, mice","Mouse embryonic fibroblasts, lymphoblastoid cell lines","TP53 :-: SLC7A11, SLC7A11 :-: Ferroptosis",Validated,_NA_,Cellular tumor antigen p53,P04637 (P53_HUMAN),27034505,p53 in article
GLS2,Glutaminase 2,HGNC:29570,"Upregulated in erastin-treated wild-type MEFs, and silencing Gls2 exihibits cell death defect in wild-type MEFs treated with erastin.","Cell viability assay,western blot",Mice,Mouse embryonic fibroblasts,GLS2 :+: Ferroptosis,Validated,_NA_,Glutaminase liver isoform,Q9UI32 (GLSL_HUMAN),27034505,_NA_
ATG5,Autophagy related 5,HGNC:589,Knockout or knockdown limited erastin-induced ferroptosis.,shRNA,"Human, mice","Mouse embryonic fibroblasts, human pancreatic cancer cell lines (PANC1 and PANC2.03), and the human fibrosarcoma cell line HT-1080",ATG5 :+: Ferroptosis,Validated,_NA_,Autophagy protein 5,Q9H1Y0 (ATG5_HUMAN),27245739,_NA_
ATG7,Autophagy related 7,HGNC:16935,Knockout or knockdown limited erastin-induced ferroptosis.,shRNA,"Human, mice","Mouse embryonic fibroblasts, human pancreatic cancer cell lines (PANC1 and PANC2.03), and the human fibrosarcoma cell line HT-1081",ATG7 :+: Ferroptosis,Validated,_NA_,Ubiquitin-like modifier-activating enzyme ATG7,O95352 (ATG7_HUMAN),27245739,_NA_
NCOA4,Nuclear receptor coactivator 4,HGNC:7671,"Inhibition suppressed ferroptosis, and overexpression promoted ferroptosis.","shRNA, gene transfection",Human,PANC1 or HT-1080 cells,"NCOA4 :-: FTH1, FTH1 :-: Ferroptosis",Validated,_NA_,Nuclear receptor coactivator 4,Q13772 (NCOA4_HUMAN),27245739,_NA_
TF,Transferrin,HGNC:11740,Involved in siramesine and lapatinib-induced ferroptotic cell death. Increased following treatment with lapatinib alone or in combination with siramesine. Knocking down of transferrin resulted in decreased cell death and ROS after treatment.,"Western blot, densitometry quantification, siRNA, gene transfection, cell death test",Human,MDA MB 231 and SKBr3 cells,"TF :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Serotransferrin,P02787 (TRFE_HUMAN),27441659,Transferrin in article
ALOX5,Arachidonate 5-lipoxygenase,HGNC:435,Silencing ALOX genes made cells resistant to ferroptosis.,qPCR,Human,G-401 cells,"ALOX5 :+: PUFAs peroxidation, PUFAs peroxidation :+: Ferroptosis",Validated,_NA_,Arachidonate 5-lipoxygenase,P09917 (LOX5_HUMAN),27506793,_NA_
ALOX12,"Arachidonate 12-lipoxygenase, 12S type",HGNC:429,Silencing ALOX genes made cells resistant to ferroptosis.,qPCR,Human,G-401 cells,"ALOX12 :+: PUFAs peroxidation, PUFAs peroxidation :+: Ferroptosis",Validated,_NA_,Arachidonate 12-lipoxygenase,P18054 (LOX12_HUMAN),27506793,_NA_
ALOX12B,"Arachidonate 12-lipoxygenase, 12R type",HGNC:430,Silencing ALOX genes made cells resistant to ferroptosis.,qPCR,Human,G-401 cells,"ALOX12B :+: PUFAs peroxidation, PUFAs peroxidation :+: Ferroptosis",Validated,_NA_,Arachidonate 12-lipoxygenase,O75342 (LX12B_HUMAN),27506793,_NA_
ALOX15,Arachidonate 15-lipoxygenase,HGNC:433,Silencing ALOX genes made cells resistant to ferroptosis.,qPCR,Human,G-401 cells,"ALOX15 :+: PUFAs peroxidation, PUFAs peroxidation :+: Ferroptosis",Validated,_NA_,Arachidonate 15-lipoxygenase,P16050 (LOX15_HUMAN),27506793,_NA_
ALOX15B,Arachidonate 15-lipoxygenase type B,HGNC:434,"Silencing ALOX genes made cells resistant to ferroptosis. Erastin-induced cell death was rescued by silencing either ALOX15B or ALOXE3, which supported the hypothesis that lipoxygenases are required for ferroptosis.","qPCR, siRNA",Human,"G-401, BJeLR and HT-1080 cells","ALOX15B :+: PUFAs peroxidation, PUFAs peroxidation :+: Ferroptosis",Validated,_NA_,Arachidonate 15-lipoxygenase B,O15296 (LX15B_HUMAN),27506793,_NA_
ALOXE3,Arachidonate lipoxygenase 3,HGNC:13743,"Silencing ALOX genes made cells resistant to ferroptosis. Erastin-induced cell death was rescued by silencing either ALOX15B or ALOXE3, which supported the hypothesis that lipoxygenases are required for ferroptosis.","qPCR, siRNA",Human,"G-401, BJeLR and HT-1080 cells","ALOXE3 :+: PUFAs peroxidation, PUFAs peroxidation :+: Ferroptosis",Validated,_NA_,Hydroperoxide isomerase ALOXE3,Q9BYJ1 (LOXE3_HUMAN),27506793,_NA_
PHKG2,Phosphorylase kinase catalytic subunit gamma 2,HGNC:8931,U-2-OS cells became resistant to erastin upon PHKG2 silencing. Erastin-treated HT-1080 cells were rescued by shPHKG2.,"shRNA suppressor screen, qPCR, cellular iron staining, cell viability",Human,"U-2-OS, HT-1080 cells","PHKG2 :+: PUFAs peroxidation, PUFAs peroxidation :+: Ferroptosis",Validated,_NA_,Phosphorylase b kinase gamma catalytic chain,P15735 (PHKG2_HUMAN),27506793,_NA_
TFRC,Transferrin receptor,HGNC:11763,The gene targets of the enriched shRNAs are potential genes that positively regulate ferroptosis.,RNAi screening,Mice,Mouse embryonic fibroblasts,"TFRC :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Screened,_NA_,Transferrin receptor protein 1,P02786 (TFR1_HUMAN),27514700,_NA_
ACO1,Aconitase 1,HGNC:117,The gene targets of the enriched shRNAs are potential genes that positively regulate ferroptosis.,RNAi screening,Mice,Mouse embryonic fibroblasts,"ACO1 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Screened,_NA_,Cytoplasmic aconitate hydratase,P21399 (ACOC_HUMAN),27514700,_NA_
IREB2,iron responsive element binding protein 2,HGNC:6115,The gene targets of the enriched shRNAs are potential genes that positively regulate ferroptosis.,RNAi screening,Mice,Mouse embryonic fibroblasts,"IREB2 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Screened,_NA_,Iron-responsive element-binding protein 2,P48200 (IREB2_HUMAN),27514700,_NA_
SLC38A1,Solute carrier family 38 member 1,HGNC:13447,The gene targets of the enriched shRNAs are potential genes that positively regulate ferroptosis.,RNAi screening,Mice,Mouse embryonic fibroblasts,"SLC38A1 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Screened,_NA_,Sodium-coupled neutral amino acid transporter 1,Q9H2H9 (S38A1_HUMAN),27514700,_NA_
GLS2,Glutaminase 2,HGNC:29570,The gene targets of the enriched shRNAs are potential genes that positively regulate ferroptosis.,RNAi screening,Mice,Mouse embryonic fibroblasts,"GLS2 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Screened,_NA_,Glutaminase liver isoform,Q9UI32 (GLSL_HUMAN),27514700,_NA_
G6PDX,_NA_,_NA_,The gene targets of the enriched shRNAs are potential genes that positively regulate ferroptosis.,RNAi screening,Mice,Mouse embryonic fibroblasts,"G6PDX :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Screened,_NA_,_NA_,_NA_,27514700,Not found in HGNC
ULK1,Unc-51 like autophagy activating kinase 1,HGNC:12558,Potential positive regulators of ferroptosis. Knockout of ULK1 led to significantly lower levels of erastin-induced ferroptosis in a dose- and time-dependent manner.,"RNAi screening, gene knockout",Mice,Mouse embryonic fibroblasts,"ULK1 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Serine/threonine-protein kinase ULK1,O75385 (ULK1_HUMAN),27514700,_NA_
ATG3,Autophagy related 3,HGNC:20962,"Potential positive regulators of ferroptosis. Knockout of ATG3 greatly reduced the sensitivity of MEFs to ferropotosis, and reconstituting ATG3 back to these cells restored the ferroptosis sensitivity.","RNAi screening, gene knockout",Mice,Mouse embryonic fibroblasts,"ATG3 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Ubiquitin-like-conjugating enzyme ATG3,Q9NT62 (ATG3_HUMAN),27514700,_NA_
ATG4D,Autophagy related 4D cysteine peptidase,HGNC:20789,Potential positive regulators of ferroptosis.,RNAi screening,Mice,Mouse embryonic fibroblasts,"ATG4D :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Screened,_NA_,Cysteine protease ATG4D,Q86TL0 (ATG4D_HUMAN),27514700,_NA_
ATG5,Autophagy related 5,HGNC:589,Potential positive regulators of ferroptosis. Knockout of ATG5 led to significantly lower levels of erastin-induced ferroptosis in a dose- and time-dependent manner.,RNAi screening,Mice,Mouse embryonic fibroblasts,"ATG5 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Autophagy protein 5,Q9H1Y0 (ATG5_HUMAN),27514700,_NA_
BECN1,Beclin 1,HGNC:1034,Potential positive regulators of ferroptosis.,RNAi screening,Mice,Mouse embryonic fibroblasts,"BECN1 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Screened,_NA_,Beclin-1,Q14457 (BECN1_HUMAN),27514700,_NA_
MAP1LC3A,Microtubule associated protein 1 light chain 3 alpha,HGNC:6838,Potential positive regulators of ferroptosis.,RNAi screening,Mice,Mouse embryonic fibroblasts,"MAP1LC3A :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Screened,_NA_,Microtubule-associated proteins 1A/1B light chain 3A,Q9H492 (MLP3A_HUMAN),27514700,_NA_
GABARAPL2,GABA type A receptor associated protein like 2,HGNC:13291,Potential positive regulators of ferroptosis.,RNAi screening,Mice,Mouse embryonic fibroblasts,"GABARAPL2 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Screened,_NA_,Gamma-aminobutyric acid receptor-associated protein-like 2,P60520 (GBRL2_HUMAN),27514700,_NA_
GABARAPL1,GABA type A receptor associated protein like 1,HGNC:4068,Potential positive regulators of ferroptosis.,RNAi screening,Mice,Mouse embryonic fibroblasts,"GABARAPL1 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Screened,_NA_,Gamma-aminobutyric acid receptor-associated protein-like 1,Q9H0R8 (GBRL1_HUMAN),27514700,_NA_
ATG16L1,Autophagy related 16 like 1,HGNC:21498,Potential positive regulators of ferroptosis.,RNAi screening,Mice,Mouse embryonic fibroblasts,"ATG16L1 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Screened,_NA_,Autophagy-related protein 16-1,Q676U5 (A16L1_HUMAN),27514700,_NA_
WIPI1,"WD repeat domain, phosphoinositide interacting 1",HGNC:25471,Potential positive regulators of ferroptosis.,RNAi screening,Mice,Mouse embryonic fibroblasts,"WIPI1 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Screened,_NA_,WD repeat domain phosphoinositide-interacting protein 1,Q5MNZ9 (WIPI1_HUMAN),27514700,_NA_
WIPI2,"WD repeat domain, phosphoinositide interacting 2",HGNC:32225,Potential positive regulators of ferroptosis.,RNAi screening,Mice,Mouse embryonic fibroblasts,"WIPI2 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Screened,_NA_,WD repeat domain phosphoinositide-interacting protein 2,Q9Y4P8 (WIPI2_HUMAN),27514700,_NA_
SNX4,Sorting nexin 4,HGNC:11175,Potential positive regulators of ferroptosis.,RNAi screening,Mice,Mouse embryonic fibroblasts,"SNX4 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Screened,_NA_,Sorting nexin-4,O95219 (SNX4_HUMAN),27514700,_NA_
ATG13,Autophagy related 13,HGNC:29091,"Knockout of ATG13 greatly reduced the sensitivity of MEFs to ferropotosis, and reconstituting ATG13 back to these cells restored the ferroptosis sensitivity.",Gene knockout,Mice,Mouse embryonic fibroblasts,"ATG13 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Autophagy-related protein 13,O75143 (ATG13_HUMAN),27514700,_NA_
ULK2,Unc-51 like autophagy activating kinase 2,HGNC:13480,Knockout of ULK2 led to significantly lower levels of erastin-induced ferroptosis in a dose- and time-dependent manner.,Gene knockout,Mice,Mouse embryonic fibroblasts,"ULK2 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Serine/threonine-protein kinase ULK2,Q8IYT8 (ULK2_HUMAN),27514700,_NA_
NCOA4,Nuclear receptor coactivator 4,HGNC:7671,Elimination of NCOA4 expression by RNAi knockdown significantly block ferroptosis,"RNAi knockdown, western blot","Human, mice",Mouse embryonic fibroblasts and HT1080 cells,"NCOA4 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Nuclear receptor coactivator 4,Q13772 (NCOA4_HUMAN),27514700,_NA_
ACSL4,Acyl-CoA synthetase long chain family member 4,HGNC:3571,"Knockdown inhibited erastin-induced ferroptosis, whereas overexpression restored ferroptosis sensitization.","shRNA, gene transfection, western blot",Human,"LNCaP (human prostate cancer cells), K562 (human erythromyeloblastoid leukemia cell line), HepG2 (human hepatocellular cells), and HL60 (human promyelocytic leukemia cells)","ACSL4 :+: 5-HETE, 5-HETE :+: Ferroptosis",Validated,_NA_,Long-chain-fatty-acid--CoA ligase 4,O60488 (ACSL4_HUMAN),27565726,_NA_
TP53,Tumor protein p53,HGNC:11998,"p53 acetylation has a critical role in ferroptotic responses. Simultaneous loss of K98/117/161/162 acetylations is unable to induce ferroptosis, and its ability to thwart cancer growth is also abrogated.","Mass spectrometry screening, western blot, cell death assay","Human, mice","H1299 cells, mouse xenograft models","TP53 :-: SLC7A11, SLC7A11 :-: Ferroptosis",Validated,_NA_,Cellular tumor antigen p53,P04637 (P53_HUMAN),27705786,_NA_
SAT1,Spermidine/spermine N1-acetyltransferase 1,HGNC:10540,p53-mediated activation of SAT1 contributes to ferroptotic cell death in the presence of ROS stress. Knockdown of Sat1 partially rescued ROS-induced ferroptosis.,"qRT-PCR, siRNA, CRISPR-cas9, western blot","Human, mice","H1299, U2OS cells, mouse embryonic fibroblasts, mouse xenograft","SAT1 :+: ALOX15, ALOX15 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,Activated by p53.,Diamine acetyltransferase 1,P21673 (SAT1_HUMAN),27698118,_NA_
ALOX15,Arachidonate 15-lipoxygenase,HGNC:433,"SAT1- and ROS-induced ferroptosis was completely abrogated by PD146176, an ALOX15-specific inhibitor.","Cell death count, qRT-PCR, siRNA",Human,"H1299, U2OS cells","ALOX15 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Arachidonate 15-lipoxygenase,P16050 (LOX15_HUMAN),27698118,_NA_
ACSL4,Acyl-CoA synthetase long chain family member 4,HGNC:3571,Inhibition of ACSL4 was effective in protecting against RSL3-induced cell death. Acsl4 KO cells are resistant to ferroptosis.,"Cell death count, LC-MS/MS,  fluorescence imaging",Mice,Mouse embryonic fibroblasts (Pfa1 cells),"ACSL4 :+: PE, PE :+: Ferroptosis",Validated,_NA_,Long-chain-fatty-acid--CoA ligase 4,O60488 (ACSL4_HUMAN),27842066,_NA_
LPCAT3,Lysophosphatidylcholine acyltransferase 3,HGNC:30244,Knockdown of Lpcat3 increased resistance to ferroptosis triggered by RSL3.,shRNA,Mice,Mouse lung epithelial (MLE) and embryonic cells,LPCAT3 :+: Ferroptosis,Validated,_NA_,Lysophospholipid acyltransferase 5,Q6P1A2 (MBOA5_HUMAN),27842066,_NA_
ALOX15,Arachidonate 15-lipoxygenase,HGNC:433,Liproxstatin-1 inhibited the 15-LOX enzymatic activity and suppressed ferroptosis.,Identification of oxygenated PE,Mice,Kidney of GPX4-deficient mice,"ALOX15 :+: PE, PE :+: Ferroptosis",Validated,_NA_,Arachidonate 15-lipoxygenase,P16050 (LOX15_HUMAN),27842066,15-LOX in article
ACSL4,Acyl-CoA synthetase long chain family member 4,HGNC:3571,An essential proferroptotic gene. Re-expression of Flag-tagged human wild-type (WT) ACSL4 (ACSL4-Flag) in Acsl4 KO Pfa1 cells restored full sensitivity to ferroptosis induction. Inhibition showed significantly prolonged survival compared to vehicle-treated mice.,"Cell viability, immunoblot,  lipid peroxidation assessment, CRISPR–Cas9, qPCR, microarray, RNA-seq","Human, mice","Mouse embryonic fibroblasts (Pfa1 cells), human breast cancer cell lines, Gpx4 KO mice",ACSL4 :+: Ferroptosis,Validated,_NA_,Long-chain-fatty-acid--CoA ligase 4,O60488 (ACSL4_HUMAN),27842070,_NA_
KEAP1,Kelch like ECH associated protein 1,HGNC:23177,Keap 1 silencing decreased ferroptosis.,"Cell viability assay, western blot, siRNA",Mice,"Head and neck cancer cells, nude mice","KEAP1 :-: NFE2L2, NFE2L2 :-: Ferroptosis",Validated,_NA_,Kelch-like ECH-associated protein 1,Q14145 (KEAP1_HUMAN),28012440,_NA_
EGFR,Epidermal growth factor receptor,HGNC:3236,Cell death in activated EGFR mutant cells occurs by ferroptosis. Inhibiting EGFR and MAPK signaling rescued cell viability following cystine withdrawal.,"Fluorescence-activated cell sorting (FACS) analysis, cell viability",Human,Human mammary epithelial) cells,"EGFR :+: MAPK, MAPK :+: Ferroptosis",Validated,_NA_,Epidermal growth factor receptor,P00533 (EGFR_HUMAN),28297659,_NA_
NOX4,NADPH oxidase 4,HGNC:7891,Inhibition of NADPH oxidase 4 (NOX4) blocked ferroptosis.,"Fluorescence-activated cell sorting (FACS) analysis, cell viability",Human,Human mammary epithelial) cells,"NOX4 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,NADPH oxidase 4,Q9NPH5 (NOX4_HUMAN),28297659,_NA_
MAPK3,Mitogen-activated protein kinase 3,HGNC:6877,Inhibiting EGFR and MAPK signaling rescued cell viability following cystine withdrawal.,"Immunoblots, lucifer yellow infiltration, cell viability, fluorescence-activated cell sorting (FACS) analysis",Human,Human mammary epithelial) cells,"MAPK :-: GPX4, GPX4 :-: Lipid ROS, MAPK :+: NOX4, NOX4 :+: H2O2, H2O2 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Mitogen-activated protein kinase 3,P27361 (MK03_HUMAN),28297659,ERK1 in article
MAPK1,Mitogen-activated protein kinase 1,HGNC:6871,Inhibiting EGFR and MAPK signaling rescued cell viability following cystine withdrawal.,"Immunoblots, lucifer yellow infiltration, cell viability, fluorescence-activated cell sorting (FACS) analysis",Human,Human mammary epithelial) cells,"MAPK :-: GPX4, GPX4 :-: Lipid ROS, MAPK :+: NOX4, NOX4 :+: H2O2, H2O2 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Mitogen-activated protein kinase 1,P28482 (MK01_HUMAN),28297659,ERK2 in article
BID,BH3 interacting domain death agonist,HGNC:1050,BID deletion prevents erastin- and glutamate-induced cell death. BID inhibition inhibited erastin-induced ferroptosis.,"Cell viability, western blot, CRISPR/Cas9, gene transfection",Mice,"HT-22 cells, mouse embryonic fibroblasts",BID :+: Ferroptosis,Validated,_NA_,BH3-interacting domain death agonist,P55957 (BID_HUMAN),28384611,_NA_
ACSL4,Acyl-CoA synthetase long chain family member 4,HGNC:3571,Knockout of Acsl4 in ferroptosis-sensitive cells conferred protection from erastin- and RSL3-induced cell death.,"CRISPR/Cas9, western blotting, cell death assessment","Human, mice","NIH3T3, HT-29, HT-1080 and L929 cells",ACSL4 :+: Ferroptosis,Validated,_NA_,Long-chain-fatty-acid--CoA ligase 4,O60488 (ACSL4_HUMAN),28551825,_NA_
ZEB1,Zinc finger E-box binding homeobox 1,HGNC:11642,Knockout of ZEB1 prevents cell death induced by GPX4 inhibition.,"sgRNA, cell viability",Human,KP4 pancreatic cancer cells,"ZEB1 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Zinc finger E-box-binding homeobox 1,P37275 (ZEB1_HUMAN),28678785,_NA_
KEAP1,Kelch like ECH associated protein 1,HGNC:23177,Keap1 inhibition promotes resistance to ferroptosis.,Cell viability analysis,"Human, rat","F98, U87 glioma cells",KEAP1 :+: Ferroptosis,Validated,_NA_,Kelch-like ECH-associated protein 1,Q14145 (KEAP1_HUMAN),28805788,_NA_
DPP4,Dipeptidyl peptidase 4,HGNC:3009,Required for ferroptosis in TP53-deficient CRC cells.,"Cell death, RNAi, western blot, enzyme activity","Human, mice","TP53-/- HCT116 cells, athymic nude mice","DPP4 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Dipeptidyl peptidase 4,P27487 (DPP4_HUMAN),28813679,_NA_
ALOX15,Arachidonate 15-lipoxygenase,HGNC:433,Suppression of ferroptosis following ALOX15 silencing was detected in cancer cells. Cells with exogenous expression of ALOX15 had an increased cell death rate following RSL3 treatment.,"siRNA, transfection, western blot, cellular lipoxygenase assay",Human,"HT1080, Panc‐1, Calu‐1 cells",ALOX15 :+: Ferroptosis,Validated,_NA_,Arachidonate 15-lipoxygenase,P16050 (LOX15_HUMAN),28837253,_NA_
ALOX12,"Arachidonate 12-lipoxygenase, 12S type",HGNC:429,"12‐LOX inhibitors prevented cell death, whereas ALOX12 overexpression significantly enhanced cell death. ALOX12 expression was gradually elevated during the erastin or RSL3 treatments, and was stable in the late stage of ferroptosis.","siRNA, transfection, western blot, cellular lipoxygenase assay",Human,"HT1080, Panc‐1, Calu‐1 cells",ALOX12 :+: Ferroptosis,Validated,_NA_,Arachidonate 12-lipoxygenase,P18054 (LOX12_HUMAN),28837253,_NA_
CDKN2A,Cyclin dependent kinase inhibitor 2A,HGNC:1787,Combination of ARF induction and ROS treatment induced ferroptotic cell death. Knockdown of endogenous ARF protected cells from ROS-induced cell death.,"RNAi, immunoblot, phase-contrast image, cell death quantification","Human, mice","H1299, SaoS2, U2OS cells, mouse embryonic fibroblasts","CDKN2A :-: NFE2L2, NFE2L2 :+: SLC7A11, SLC7A11 :-: Ferroptosis, CDKN2A :+: p53, p53 :-: SLC7A11, SLC7A11 :-: Ferroptosis",Validated,_NA_,Cyclin-dependent kinase inhibitor 2A,P42771 (CDN2A_HUMAN),28985506,ARF in article
PEBP1,Phosphatidylethanolamine binding protein 1,HGNC:8630,Elevated levels of PEBP1 resulted in increased sensitivity of HK2 cells to RSL3 whereas lowered contents of PEBP1 in HAEC and HT22 cells were associated with decreased sensitivity to ferroptosis.,"Western blot, siRNA, cell death assay","Human, mice","HK2, HAEC and HT22 cells",(PEBP1/15LO) :+: Ferroptosis,Validated,_NA_,Phosphatidylethanolamine-binding protein 1,P30086 (PEBP1_HUMAN),29053969,_NA_
SOCS1,Suppressor of cytokine signaling 1,HGNC:19383,"Expression of SOCS1 sensitized cells to ferroptosis inducer. This effect of SOCS1 was efficiently blocked by ferroptosis inhibitor. Expression of SOCS1 reduced the levels of GSH, explaining in part its ability to sensitize cells to ferroptosis.","Cell death assay, cell viability assay, qPCR",Human,U2OS or IMR90 cells,"SOCS1 :+: p53, p53 :-: SLC7A11, SLC7A11 :+: GSH, GSH :-: Ferroptosis",Validated,_NA_,Suppressor of cytokine signaling 1,O15524 (SOCS1_HUMAN),29081404,_NA_
CDO1,Cysteine dioxygenase type 1,HGNC:1795,CDO1 suppression contributes to ferroptosis resistance.,"siRNA, western blot, MTT assay",Human,"Gastric cancer cells AGS, BGC823, athymic nude mice","CDO1 :-: GPX4, GPX4 :-: Ferroptosis",Validated,_NA_,Cysteine dioxygenase type 1,Q16878 (CDO1_HUMAN),29144989,_NA_
MYB,"MYB proto-oncogene, transcription factor",HGNC:7545,Erastin-induced ferroptosis was restrained when c-Myb was suppressed.,"Western blot, siRNA, qRT-PCR, MTT assay",Human,"Gastric cancer cells AGS, BGC823, MKN45, SGC7901, and MGC803","MYB :+: CDO1, CDO1 :-: GPX4, GPX4 :-: Ferroptosis",Validated,_NA_,Transcriptional activator Myb,P10242 (MYB_HUMAN),29144989,C-Myb in article
HMOX1,Heme oxygenase 1,HGNC:5013,Inhibiting HO-1 effectively attenuated BAY-induced ferroptotic cell death. Defective HO-1 expression significantly rescued cell survival suppressed by BAY.,"Cell viability assay, qRT-PCR, shRNA, gene overexpression, western blot",Human,"MDA-MB-231, MDA-MB-468",HMOX1 :+: Ferroptosis,Validated,_NA_,Heme oxygenase 1,P09601 (HMOX1_HUMAN),29274359,HO-1 in article
MAPK8,Mitogen-activated protein kinase 8,HGNC:6881,JNK1/2 inhibitors inhibited t-BHP-induced ferroptosis. t-BHP treatment significantly increased the protein expression of p-JNK.,"MitoSOX probe, luminometer kit, C11-BODIPY probe, western blot",Rat,PC12 cells,"MAPK8 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Mitogen-activated protein kinase 8,P45983 (MK08_HUMAN),29330409,JNK1 in article
MAPK9,Mitogen-activated protein kinase 9,HGNC:6886,JNK1/2 inhibitors inhibited t-BHP-induced ferroptosis. t-BHP treatment significantly increased the protein expression of p-JNK.,"MitoSOX probe, luminometer kit, C11-BODIPY probe, western blot",Rat,PC12 cells,"MAPK9 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Mitogen-activated protein kinase 9,P45984 (MK09_HUMAN),29330409,JNK2 in article
MAPK1,Mitogen-activated protein kinase 1,HGNC:6871,ERK1/2 inhibitors inhibited t-BHP-induced ferroptosis. t-BHP treatment significantly increased the protein expression of p-ERK.,"MitoSOX probe, luminometer kit, C11-BODIPY probe, western blot",Rat,PC12 cells,"MAPK1 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Mitogen-activated protein kinase 1,P28482 (MK01_HUMAN),29330409,ERK2 in article
MAPK3,Mitogen-activated protein kinase 3,HGNC:6877,ERK1/2 inhibitors inhibited t-BHP-induced ferroptosis. t-BHP treatment significantly increased the protein expression of p-ERK.,"MitoSOX probe, luminometer kit, C11-BODIPY probe, western blot",Rat,PC12 cells,"MAPK3 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Mitogen-activated protein kinase 3,P27361 (MK03_HUMAN),29330409,ERK1 in article
SLC1A5,Solute carrier family 1 member 5,HGNC:10943,Overexpression of SLC1A5 restored miR-137-mediated ferroptosis suppression.,"Cell viability assay, lipid ROS assay, western blot, gene overexpression, shRNA",Human,Melanoma cell lines A375 and G-361,"SLC1A5 :+: Glutaminolysis, Glutaminolysis :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Neutral amino acid transporter B(0),Q15758 (AAAT_HUMAN),29348676,_NA_
CHAC1,ChaC glutathione specific gamma-glutamylcyclotransferase 1,HGNC:28680,CHAC1 degradation of GSH might enhance cystine-starvation-induced cell death.,"Western blot, real-time PCR, cell viability assay, siRNA, GSH assay kit",Human,"MDA-MB-231, Hs 578T, and HCC 1937 cells","CHAC1 :-: GSH, GSH :-: Ferroptosis",Validated,_NA_,Glutathione-specific gamma-glutamylcyclotransferase 1,Q9BUX1 (CHAC1_HUMAN),29383104,_NA_
MAPK14,Mitogen-activated protein kinase 14,HGNC:6876,Ferroptosis was blocked by inhibiting p38 MAPK activation.,"Cell viability assay, lipid ROS measurement, RT-qPCR, western blot",Mice,TM4 Sertoli cells,MAPK14 :+: Ferroptosis,Validated,_NA_,Mitogen-activated protein kinase 14,Q16539 (MK14_HUMAN),29436589,p38 MAPK in article
LINC00472,Long intergenic non-protein coding RNA 472,HGNC:21380,"Increases erastin-induced growth inhibition, whereas depletion of P53RRA decreased erastin-induced growth inhibition.","Bisulfite sequencing, RNA pull-down, mass spectrometry, RNA immunoprecipitation, qRT-PCR, cell viability assay",Human,"Lung cancer A549, SPCA1, and H522 cells","LINC00472 :+: p53, p53 :+: Ferroptosis",Validated,Also triggers apoptosis.,Putative uncharacterized protein encoded by LINC00472,Q9H8W2 (CF155_HUMAN),29588351,P53RRA in article
NOX4,NADPH oxidase 4,HGNC:7891,Activated  Nox4  contributes to  PAB-induced  ferroptotic cell death. knockdown made cells resistant to PAB-induced death.,"Western blot, LDH release assay, siRNA, cell death, siRNA","Human, rat","Rat C6, human SHG-44, U87 and U251 glioma cells","NOX4 :+: H2O2, H2O2 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,NADPH oxidase 4,Q9NPH5 (NOX4_HUMAN),29702192,_NA_
GOT1,Glutamic-oxaloacetic transaminase 1,HGNC:4432,"Overexpression of miR‐9 suppressed GOT1, which subsequently reduced ferroptosis. Overexpression of GOT1 restored miR‐9 mediated ferroptosis suppression.","Immunoblotting, luciferase reporter assay, qPCR, cell viability assay, MDA assay, iron assay, glutamate assay",Human,A375 and G‐361 cells,"GOT1 :+: alpha KG, alpha KG :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Aspartate aminotransferase,P17174 (AATC_HUMAN),30035324,_NA_
BECN1,Beclin 1,HGNC:1034,Knockdown inhibits ferroptosis. Overexpression increases ferroptotic cancer cell death.,"shRNA, western blot, cell viability assay, gene overexpression","Human, mice","HCT116, CX-1, PANC1, HT1080, and Calu-1 cells, athymic nude immunodeficient mice","BECN1 :-: System Xc-, System Xc- :+: GSH, GSH :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Beclin-1,Q14457 (BECN1_HUMAN),30057310,_NA_
PRKAA2,Protein kinase AMP-activated catalytic subunit alpha 2,HGNC:9377,Inhibition of PRKAA/AMPKalpha diminishes ferroptosis.,"siRNA, western blot, cell viability assay, GSH assay, lipid peroxidation assay, iron assay",Human,HCT116 and CX-1 cells,"PRKAA2 :+: (BECN1/SLC7A11), (BECN1/SLC7A11) :+: Ferroptosis",Validated,_NA_,5'-AMP-activated protein kinase catalytic subunit alpha-2,P54646 (AAPK2_HUMAN),30057310,PRKAA in article
PRKAA1,Protein kinase AMP-activated catalytic subunit alpha 1,HGNC:9376,Inhibition of PRKAA/AMPKalpha diminishes ferroptosis.,"siRNA, western blot, cell viability assay, GSH assay, lipid peroxidation assay, iron assay",Human,HCT116 and CX-1 cells,"PRKAA1 :+: (BECN1/SLC7A11), (BECN1/SLC7A11) :+: Ferroptosis",Validated,_NA_,5'-AMP-activated protein kinase catalytic subunit alpha-1,Q13131 (AAPK1_HUMAN),30057310,AMPK alpha in article
ELAVL1,ELAV like RNA binding protein 1,HGNC:3312,"ELAVL1 siRNA led to ferroptosis resistance, whereas ELAVL1 plasmid contributed to classical ferroptotic events.","Immunohistochemistry, hydroxyproline assay, immunofluorescence, cell viability assay, western blot, qPCR, iron assay, ROS assay, RNAi","Human, mice",Human liver specimens and hepatic stellate cell; C57BL/6 mice; mouse hepatocyte and hepatic stellate cell; HSC-LX2 and HSC-T6 cells,ELAVL1 :+: Ferroptosis,Validated,_NA_,ELAV-like protein 1,Q15717 (ELAV1_HUMAN),30081711,_NA_
BAP1,BRCA1 associated protein 1,HGNC:950,Suppresses SLC7A11-mediated cystine uptake and promotes ferroptosis. BAP1 mutants lose their abilities to repress SLC7A11 and to promote ferroptosis.,"Flow cytometry, cell viability assay, cell death assay, western blot, gene knockout, lipid peroxidation assay, cystine uptake assay, GSH assay, RT-PCR, ChIP-qPCR, luciferase reporter assay, immunoprecipitation, IHC, ChIP-seq",Human,"HEK-293T, Caki1, 786-O, 769-P, ACHN and NCI-H226 cell lines; RCC4,  UMRC2, SLR20, and UMRC6 cell lines; TK10 cell line; athymic nude mice","BAP1 :-: SLC7A11, SLC7A11 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Ubiquitin carboxyl-terminal hydrolase BAP1,Q92560 (BAP1_HUMAN),30202049,_NA_
TP53,Tumor protein p53,HGNC:11998,"Facilitates ART-induced ferroptosis. Conversely, knockdown of P53 blocked ART-induced ferroptosis.","Western blot, immunofluorescence, siRNA",Rat,Hepatic stellate cell HSC‐T6,TP53 :+: Ferroptosis,Validated,_NA_,Cellular tumor antigen p53,P04637 (P53_HUMAN),30321484,P53 in article
ABCC1,ATP binding cassette subfamily C member 1,HGNC:51,Accelerates ferroptosis. Disruption of MRP1 inhibited ferroptosis potently.,"Western blot, GSH assay, dead cell counts, gene transfection, CRISPR/Cas9, cell viability assay, RT-qPCR",Human,"HAP1, H1299, U-2 OS cells","ABCC1 :-: GSH, GSH :-: Ferroptosis",Validated,_NA_,Multidrug resistance-associated protein 1,P33527 (MRP1_HUMAN),30726737,MRP1 in article
ACSL4,Acyl-CoA synthetase long chain family member 4,HGNC:3571,Inhibition suppresses ferroptosis.,"siRNA, western blot, microscopy imaging, fluorescence microscopy, real-time PCR","Human, mice","Male C57BL/6 mice, Caco-2 cells","ACSL4 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Long-chain-fatty-acid--CoA ligase 4,O60488 (ACSL4_HUMAN),30737476,_NA_
MIR6852,microRNA 6852,HGNC:49993,Promotes ferroptosis. Binds to LINC0033 and serves as a negative upstream regulator of CBS-mediated ferroptosis inhibition.,"qRT-PCR, gene knockdown, luciferase assay, gene overexpression, MTT assay, colony-formation assay",Human,A549 and SPC-A-1 cells,"MIR6852 :-: CBS, CBS :-: Ferroptosis",Validated,_NA_,_NA_,_NA_,30787392,_NA_
ACVR1B,Activin A receptor type 1B,HGNC:172,Inhibition attenuated erastin-induced ferroptosis.,"Western blot, siRNA, glutathione assay, RT-PCR, cell viability assay",Human,HK-2 cells,"ACVR1B :-: NFE2L2, NFE2L2 :-: Ferroptosis ",Validated,_NA_,Activin receptor type-1B,P36896 (ACV1B_HUMAN),30804470,ALK4 in article
TGFBR1,Transforming growth factor beta receptor 1,HGNC:11772,Inhibition attenuated erastin-induced ferroptosis.,"Western blot, siRNA, glutathione assay, RT-PCR, cell viability assay",Human,HK-2 cells,"TGFBR1 :-: NFE2L2, NFE2L2 :-: Ferroptosis",Validated,_NA_,TGF-beta receptor type-1,P36897 (TGFR1_HUMAN),30804470,ALK5 in article
BAP1,BRCA1 associated protein 1,HGNC:950,Promotes ferroptosis induced by class I ferroptosis inducer.,"Immunoprecipitation, western blotting, cell death, cell viability, RT-PCR",Human,HEK293T cells,"BAP1 :-: SLC7A11, SLC7A11 :-: Ferroptosis",Validated,_NA_,Ubiquitin carboxyl-terminal hydrolase BAP1,Q92560 (BAP1_HUMAN),30907299,_NA_
EPAS1,Endothelial PAS domain protein 1,HGNC:3374,A driver of ferroptosis susceptibility. Ablation reduced susceptibility to ferroptosis.,"CRISPR, sgRNA, shRNA, immunoblot, cell viability, western blot",Mice,786-O cells,"EPAS1 :+: HILPDA, EPAS1 :+: PLIN2, HILPDA :+: PUFA, PLIN2 :+: PUFA, PUFA :+: PUFA-phospholipid hydroperoxides, PUFA-phospholipid hydroperoxides :+: Ferroptosis",Validated,_NA_,Endothelial PAS domain-containing protein 1,Q99814 (EPAS1_HUMAN),30962421,HIF-2alpha in article
HILPDA,Hypoxia inducible lipid droplet associated,HGNC:28859,Promotes ferroptosis sensitivity downstream of HIF-2alpha.,"RNA-Seq, western blot, qRT-PCR, shRNA, cell viability, immunoblot ",Mice,786-O cells,"HILPDA :+: PUFA, PUFA :+: PUFA-phospholipid hydroperoxides, PUFA-phospholipid hydroperoxides :+: Ferroptosis",Validated,_NA_,Hypoxia-inducible lipid droplet-associated protein,Q9Y5L2 (HLPDA_HUMAN),30962421,_NA_
HIF1A,Hypoxia inducible factor 1 subunit alpha,HGNC:4910,Re-sensitized HIF-2alpha-null cells to ferroptosis.  Induce ferroptosis sensitivity in cancer cells.,"cDNA screenin, cell viability",Mice,786-O cells,"HIF1A :+: HILPDA, HIF1A :+: PLIN2, HILPDA :+: PUFA, PLIN2 :+: PUFA, PUFA :+: PUFA-phospholipid hydroperoxides, PUFA-phospholipid hydroperoxides :+: Ferroptosis",Validated,_NA_,Hypoxia-inducible factor 1-alpha,Q16665 (HIF1A_HUMAN),30962421,HIF-1alpha in article
ALOX12,"Arachidonate 12-lipoxygenase, 12S type",HGNC:429,An essential factor of p53-dependent ferroptosis. Loss of one Alox12 allele is sufficient to abrogate p53-mediated ferroptosis.,"RNAi, qRT-PCR, western blot, CRISPR, cell death assay, GSH measurement, flow cytometer","Human, mice","H1299 cells, U2OS cells, mouse embryonic fibroblasts, mice","ALOX12 :+: PUFAs-OOH, PUFAs-OOH :+: Ferroptosis",Validated,_NA_,Arachidonate 12-lipoxygenase,P18054 (LOX12_HUMAN),30962574,_NA_
ACSL4,Acyl-CoA synthetase long chain family member 4,HGNC:3571,Required for ferroptosis induced by erastin. ACSL4-null cells are resistant to ferroptosis induced by either erastin.,"Western blot, cell death assay, CRISPR",Human,U2OS,ACSL4 :+: Ferroptosis,Validated,_NA_,Long-chain-fatty-acid--CoA ligase 4,O60488 (ACSL4_HUMAN),30962574,_NA_
HMOX1,Heme oxygenase 1,HGNC:5013,Enhances the ferroptotic process in PRDX6-silenced cells by promoting cellular accumulation of ferrous ions. Overexpression increases both erastin and RSL-3-induced lipid ROS.,"Gene transfection, western blot, qRT-PCR, LOOH quantification",Human,H1299 cells,HMOX1 :+: Ferroptosis,Validated,_NA_,Heme oxygenase 1,P09601 (HMOX1_HUMAN),31036877,_NA_
IFNG,Interferon gamma,HGNC:5438,"Interferon gamma released from CD8+ T cells downregulates the expression of SLC3A2 and SLC7A11, and as a consequence, promotes tumour cell lipid peroxidation and ferroptosis.","BODIPY-C11, liperfluo staining, cell death measurement, FACS, cell proliferation and viability assay, qPCR, immunoblotting, glutathione quantification, MDA assay, glutamate assay","Human, mice","HT-1080, A375, B16-F0, ID8 cells, female NSG and C57BL/6 mice","IFNG :-: SLC3A2, IFNG :-: SLC7A11, SLC3A2 :+: System Xc-, SLC7A11 :+: System Xc-, System Xc- :+: Cystine, Cystine :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Interferon gamma,P01579 (IFNG_HUMAN),31043744,IFNgamma in article
ANO6,Anoctamin 6,HGNC:25240,Essential for ferroptosis. Inhibition blocked ferroptotic cell death induced by RSL3/erastin.,"Immunocytochemistry, RT-PCR, TUNEL Assay, flow Cytometry, LDH assay, gene knockout, siRNA","Human, mice","A549, Cal27, HT29 and MG-63 cells, Cx3cr1-Cre mice",ANO6 :+: Ferroptosis,Validated,_NA_,Anoctamin-6,Q4KMQ2 (ANO6_HUMAN),31060306,_NA_
LPIN1,Lipin 1,HGNC:13345,Overexpression of adipose lipin‐1 in mice facilitated the onset of hepatic ferroptosis.,"Enzyme‐linked immunosorbent assay, lipid peroxidation assay, iron assay, MDA assay, qPCR, GSH assay",Mice,C57BL/6 mice,LPIN1 :+: Ferroptosis,Validated,_NA_,Phosphatidate phosphatase LPIN1,Q14693 (LPIN1_HUMAN),31061954,_NA_
HMGB1,High mobility group box 1,HGNC:4983,Required for erastin-induced ferroptosis. Knockdown of HMGB1 decreased erastin-induced cell death.,"Gene transfection, RNAi, cell viability assay, ELISA, LDH assay, flow cytometry, qPCR, western blot, electron microscopy","Human, mice","HL-60 cell, male NOD/SCID mice",HMGB1 :+: Ferroptosis,Validated,_NA_,High mobility group protein B1,P09429 (HMGB1_HUMAN),31105999,_NA_
TNFAIP3,TNF alpha induced protein 3,HGNC:11896,"Overexpression increased ROS generation and enhanced erastin-induced ferroptosis, whereas knockdown inhibited erastin-induced ferroptosis.","Lentivirus transduction, CCK-8 assay, DYE670 staining assay, ROS staining assay, RT-qPCR, western blot",Human,HUVEC cells,"TNFAIP3 :+: ACSL4, ACSL4 :+: Lipid ROS, TNFAIP3 :-: GPX4, GPX4 :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Tumor necrosis factor alpha-induced protein 3,P21580 (TNAP3_HUMAN),31160087,Zinc lipoprotein A20 in article
TLR4,Toll like receptor 4,HGNC:11850,Knockdown inhibited ferroptosis.,"Immunohistochemistry, western blot, cell death assay, siRNA",Rat,Sprague Dawley rats,TLR4 :+: Ferroptosis,Validated,_NA_,Toll-like receptor 4,O00206 (TLR4_HUMAN),31196626,_NA_
NOX4,NADPH oxidase 4,HGNC:7891,Knockdown inhibited ferroptosis.,"Immunohistochemistry, western blot, cell death assay, siRNA",Rat,Sprague Dawley rats,NOX4 :+: Ferroptosis,Validated,_NA_,NADPH oxidase 4,Q9NPH5 (NOX4_HUMAN),31196626,_NA_
ATF3,Activating transcription factor 3,HGNC:785,Promotes ferroptosis induced by erastin.,"Cell viability assay, transfection, lentiviral infection, qRT-PCR, western blot",Human,"HT1080 cells, retinal pigment epithelial cells","ATF3 :-: SLC7A11, SLC7A11 :+: System Xc-, System Xc- :+: GSH, GSH :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Cyclic AMP-dependent transcription factor ATF-3,P18847 (ATF3_HUMAN),31273299,_NA_
ATM,ATM serine/threonine kinase,HGNC:795,Essential for ferroptosis. Genetic knockdown and chemical inhibition of ATM both suppress ferroptotic cell death.,"siRNA, western blot, nuclear/cytosol fraction, cell viability, cell death, GSH assay, kinome screen, qRT-PCR, immunofluorescence assay",Human,"MDA-MB-231, RCC4, 293T, and HT-1080 cell lines","ATM :-: MTF1, MTF1 :+: FTL, MTF1 :+: FTH1, FTL :-: Ferroptosis, FTH1 :-: Ferroptosis",Validated,_NA_,Serine-protein kinase ATM,Q13315 (ATM_HUMAN),31320750,_NA_
YY1AP1,YY1 associated protein 1,HGNC:30935,Makes cells more sensitive to ferroptosis. Cells lacking YAP were no longer sensitised to ferroptosis.,"Cell death, cell viability, lipid peroxidation, immunoblotting, CRISPR/Cas9, ChIP assay, qRT-PCR","Human, mice","Mouse embryonic fibroblasts, NF639 cells, human epithelial tumour cells, human mesothelioma cells, xenograft mouse","YAP :+: ACSL4, ACSL4 :+: Ferroptosis, YAP :+: TFRC,  TFRC :+: Ferroptosis",Validated,_NA_,YY1-associated protein 1,Q9H869 (YYAP1_HUMAN),31341276,YAP in article
EGLN2,Egl-9 family hypoxia inducible factor 2,HGNC:14660,Inhibiting EGLN2 activation diminished ferroptotic tumor cell death.,"Cytotoxicity assays, western blot, immunoprecipitation, RNA interference, gene transfection, qPCR, MDA assay","Human, mice","Calu-1, THP1, HT1080, and HL-60 cells, athymic nude mice","EGLN2 :-: HIF1A, HIF1A  :-: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Egl nine homolog 2,Q96KS0 (EGLN2_HUMAN),31355331,_NA_
MIOX,Myo-inositol oxygenase,HGNC:14522,"Overexpression exacerbates cell death, knockdown inhibits ferroptosis.","MTT assay, measurement of GPX4 activity, labile iron pool assay, evaluation of cell death and cell morphology, immunohistochemical staining","Human, mice","HK-2 cells, C57BL/6J mice","MIOX :-: GPX4, GPX4 :-: Ferroptosis, MIOX :-: GSH, GSH :-: Ferroptosis",Validated,_NA_,Inositol oxygenase,Q9UGB7 (MIOX_HUMAN),31437128,_NA_
TAZ,Tafazzin,HGNC:11577,"TAZ removal confers ferroptosis resistance, whereas overexpression of TAZS89A sensitizes cells to ferroptosis.","Cell viability, cell death, western blot, siRNA, qRT-PCR, microarray, immunofluorescence staining, ChIP-seq, Lipid ROS assay","Human, mice"," RCC4, 786O cells, JAX NOD.CB17-PrkdcSCID-J mice","TAZ :+: EMP1, EMP1 :+: NOX4, NOX4 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Tafazzin,Q16635 (TAZ_HUMAN),31484063,_NA_
MTDH,Metadherin,HGNC:29608,Can enhance sensitivity to inducers of ferroptosis. Enhances the vulnerability of cancer cells to ferroptosis.,"Cell viability, qRT-PCR, western blotting, GSH assay, GPx4 activity assay, tumor xenograft model","Human, mice","Cell lines A549, H1975, DMS53, DMS273, KLE, AN3CA, RL95, Hec1A, Ishikawa, MDA-MB-231, MCF-7, Hec50, immunodeficient mice","MTDH :-: Cysteine, Cystein :-: Ferroptosis, MTDH :-: SLC3A2, SLC3A2 :-: Ferroptosis, MTDH :-: GPX4, GPX4 :-: Ferroptosis, MTDH :-: GSH, GSH :-: Ferroptosis, MTDH :+: Glutamate, Glutamate :+: Ferroptosis",Validated,_NA_,Protein LYRIC,Q86UE4 (LYRIC_HUMAN),31527591,_NA_
IDH1,Isocitrate dehydrogenase (NADP(+)) 1,HGNC:5382,Deletion of the mutant IDH1 allele or pharmacological inhibition of mutant IDH1 confers resistance to erastin-induced ferroptosis. Ectopic expression of mutant IDH1 promotes ferroptosis.,"Cell transfection, cell viability, GSH assay, lipid ROS assay",Human,"HEK293T, HT-1080 and KYSE-170 cells","IDH1 :-: GPX4, GPX4 :-: Lipid ROS, Lipid ROS :+: Ferroptosis, IDH1 :-: GSH, GSH :-: Ferroptosis",Validated,_NA_,Isocitrate dehydrogenase [NADP] cytoplasmic,O75874 (IDHC_HUMAN),31591388,_NA_
SIRT1,Sirtuin 1,HGNC:14929,Knockout partially mitigates ferroptosis.,"Lipid peroxidation, iron and GSH assay, qRT-PCR, western blot",Mice,Mice in C57BL/6 background,SIRT1 :+: Ferroptosis,Predicted,_NA_,NAD-dependent protein deacetylase sirtuin-1,Q96EB6 (SIR1_HUMAN),31610175,_NA_
TAZ,Tafazzin,HGNC:11577,"TAZ removal confers ferroptosis resistance, while TAZS89A overexpression sensitizes cells to ferroptosis.","siRNA, qRT-PCR, western blot, cell viability, lipid ROS assay",Human,"TOV-21G, CAOV2, CAOV2R, MDA-MB-231 cells","TAZ :+: ANGPTL4, ANGPTL4 :+: NOX2, NOX2 :+: Ferroptosis",Validated,_NA_,Tafazzin,Q16635 (TAZ_HUMAN),31641008,_NA_
BECN1,Beclin 1,HGNC:1034,Overexpression aggravated isoflurane-induced cell damage by upregulating ferroptosis. This phenomenon was significantly attenuated by silencing of Beclin1.,"Cell viability, RNAi, RT-qPCR, western blot, lipid peroxidation, iron, GSH and glutamate release assays",Human,SH-SY5Y cells,"(Beclin1/SLC7A11) :-: System Xc-, System Xc- :-: Ferroptosis",Validated,_NA_,Beclin-1,Q14457 (BECN1_HUMAN),31650158,Beclin1 in article
FBXW7,F-box and WD repeat domain containing 7,HGNC:16712,FBXW7 plasmid induces ferroptosis.,"Cell viability, lipid peroxidation, iron, GSH and ROS assays, western blot, RT-PCR, RNA-seq","Human, mice","Hepatic stellate cells, C57BL/6 mice",FBXW7 :+: Ferroptosis,Deduced,_NA_,F-box/WD repeat-containing protein 7,Q969H0 (FBXW7_HUMAN),31679460,_NA_
PANX1,Pannexin 1,HGNC:8599,Deletion protects against ferroptotic cell death. Silenced Panx1 expression significantly attenuated ferroptotic lipid peroxidation and iron accumulation induced by the ferroptosis inducer erastin.,"Cell viability, cell death, qRT-PCR, western blot, lipid peroxidation detection, shRNA","Human, mice","HK-2 cells, C57BL/6 mice","PANX1 :-: HMOX1, HMOX1 :-: Ferroptosis, PANX1 :+: MAPK/ERK, MAPK/ERK :+: Ferroptinophagy, Ferroptinophagy :+: Ferroptosis",Validated,_NA_,Pannexin-1,Q96RD7 (PANX1_HUMAN),31694915,_NA_
DNAJB6,DnaJ heat shock protein family (Hsp40) member B6,HGNC:14888,Promotes ferroptosis in esophageal squamous cell carcinoma.,"Western blot, immunohistochemistry,lentivirus infection, colony-forming, RT‑qPCR, CCK-8, transwell and mouse xenograft assays","Human, mice","Cell lines TE-1, Eca9706, Eca109, KYSE150, and KYSE450, BALB/c athymic nude mice","DNAJB6 :-: GPX4, GPX4 :-: Ferroptosis",Predicted,_NA_,DnaJ homolog subfamily B member 6,O75190 (DNJB6_HUMAN),31701262,_NA_
BACH1,BTB domain and CNC homolog 1,HGNC:935,Promotes ferroptosis by repressing the transcription of a subset of the erastin-induced protective genes.,"Western blotting, qPCR, cell death, labile iron detection, RNA-seq",Mice,"C57BL/6J mice, mouse embryonic fibroblasts","BACH1 :+: Lipid ROS, Lipid ROS :+: Ferroptosis",Validated,_NA_,Transcription regulator protein BACH1,O14867 (BACH1_HUMAN),31740582,_NA_
ACSL4,Acyl-CoA synthetase long chain family member 4,HGNC:3571,Overexpression induced ferroptosis. The opposite results were observed when ACSL4 was silenced.,"Western blotting, immunofluorescence, 5‑HETE, LDH and CCK-8 cell viability assay",Human,"HEB, T98G, U87 MG and U251 cells","ACSL4 :-: GPX4, GPX4 :-: Ferroptosis",Validated,_NA_,Long-chain-fatty-acid--CoA ligase 4,O60488 (ACSL4_HUMAN),31789401,_NA_
LONP1,"Lon peptidase 1, mitochondrial",HGNC:9479,Inhibition of LONP1 negatively regulates erastin-induced cell death.,"Cell viability, western blot, qRT-PCR, lipid peroxidation assay, glutathione assay",Human,"PANC1, BxPC3 cells","LONP1 :-: Nrf2/Keap1 pathway, Nrf2/Keap1 pathway :-: Ferroptosis, LONP1 :-: GPX4, GPX4 :-: Ferroptosis",Validated,_NA_,"Lon protease homolog, mitochondrial",P36776 (LONM_HUMAN),31822343,_NA_